NCT02819960 2022-12-14Prevention of Irinotecan Induced Diarrhea by ProbioticsS&D Pharma SK s.r.o.Phase 3 Completed233 enrolled
NCT01179217 2020-08-19A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemiaEmmaus Medical, Inc.Phase 3 Completed230 enrolled 19 charts 1 FDA